Getting above 100M will be an important threshold to cross for PSDV. One positive factor from the new outstanding share count will be that when the next catalyst occurs, there will be 15% more of them to effect the market cap. PSDV is sooo tiny and gets no respect in the investment community, largely due to its market cap. Many investment brokerages "don't"or "cant" invest in these small companies. Think about it, PSDV is still firmly in the grips of the "penny stock" paradigm. When the next catalyst hits and we move a buck or two up, we'll get a lot more recognition in the investment community. Are we seriously thinking that big pharmas aren't licking their chops at possibilities that PSDV might provide them through sustained release. It's the fricken' "HOLY GRAIL" in big pharma. Hang on to your shares.
Isn't the next catalyst the PDUFA date set for mid October followed by an NDA submission perhaps a few months after that? Please correct my if I am wrong as this is the best of my knowledge. (I am trying to follow way to many stocks for my own good :/ )